Global ß-Nicotinamide Mononucleotide Market Research Report 2024(Status and Outlook)

Global β-Nicotinamide Mononucleotide Market Research Report 2024(Status and Outlook)



Report Overview:

Beta-Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide.

The Global β-Nicotinamide Mononucleotide Market Size was estimated at USD 280.53 million in 2023 and is projected to reach USD 455.15 million by 2029, exhibiting a CAGR of 8.40% during the forecast period.

This report provides a deep insight into the global β-Nicotinamide Mononucleotide market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global β-Nicotinamide Mononucleotide Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the β-Nicotinamide Mononucleotide market in any manner.

Global β-Nicotinamide Mononucleotide Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

GeneHarbor

Quicksilver Scientific

Age Science

Herbalmax

Genex Formulas

Nutravita

Shinkowa Pharmaceutical

Oriental Yeast

Maac10 Formulas

EffePharm

Nutriop

Bontac

CELFULL

ChromaDex

Kingdomway

Market Segmentation (by Type)

by Purity

Above 98%

<98%

Market Segmentation (by Application)

Drug

Health Products

Cosmetic

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the β-Nicotinamide Mononucleotide Market

Overview of the regional outlook of the β-Nicotinamide Mononucleotide Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the β-Nicotinamide Mononucleotide Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of β-Nicotinamide Mononucleotide
1.2 Key Market Segments
1.2.1 β-Nicotinamide Mononucleotide Segment by Type
1.2.2 β-Nicotinamide Mononucleotide Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 β-Nicotinamide Mononucleotide Market Overview
2.1 Global Market Overview
2.1.1 Global β-Nicotinamide Mononucleotide Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global β-Nicotinamide Mononucleotide Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 β-Nicotinamide Mononucleotide Market Competitive Landscape
3.1 Global β-Nicotinamide Mononucleotide Sales by Manufacturers (2019-2024)
3.2 Global β-Nicotinamide Mononucleotide Revenue Market Share by Manufacturers (2019-2024)
3.3 β-Nicotinamide Mononucleotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global β-Nicotinamide Mononucleotide Average Price by Manufacturers (2019-2024)
3.5 Manufacturers β-Nicotinamide Mononucleotide Sales Sites, Area Served, Product Type
3.6 β-Nicotinamide Mononucleotide Market Competitive Situation and Trends
3.6.1 β-Nicotinamide Mononucleotide Market Concentration Rate
3.6.2 Global 5 and 10 Largest β-Nicotinamide Mononucleotide Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 β-Nicotinamide Mononucleotide Industry Chain Analysis
4.1 β-Nicotinamide Mononucleotide Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of β-Nicotinamide Mononucleotide Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 β-Nicotinamide Mononucleotide Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global β-Nicotinamide Mononucleotide Sales Market Share by Type (2019-2024)
6.3 Global β-Nicotinamide Mononucleotide Market Size Market Share by Type (2019-2024)
6.4 Global β-Nicotinamide Mononucleotide Price by Type (2019-2024)
7 β-Nicotinamide Mononucleotide Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global β-Nicotinamide Mononucleotide Market Sales by Application (2019-2024)
7.3 Global β-Nicotinamide Mononucleotide Market Size (M USD) by Application (2019-2024)
7.4 Global β-Nicotinamide Mononucleotide Sales Growth Rate by Application (2019-2024)
8 β-Nicotinamide Mononucleotide Market Segmentation by Region
8.1 Global β-Nicotinamide Mononucleotide Sales by Region
8.1.1 Global β-Nicotinamide Mononucleotide Sales by Region
8.1.2 Global β-Nicotinamide Mononucleotide Sales Market Share by Region
8.2 North America
8.2.1 North America β-Nicotinamide Mononucleotide Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe β-Nicotinamide Mononucleotide Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific β-Nicotinamide Mononucleotide Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America β-Nicotinamide Mononucleotide Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa β-Nicotinamide Mononucleotide Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 GeneHarbor
9.1.1 GeneHarbor β-Nicotinamide Mononucleotide Basic Information
9.1.2 GeneHarbor β-Nicotinamide Mononucleotide Product Overview
9.1.3 GeneHarbor β-Nicotinamide Mononucleotide Product Market Performance
9.1.4 GeneHarbor Business Overview
9.1.5 GeneHarbor β-Nicotinamide Mononucleotide SWOT Analysis
9.1.6 GeneHarbor Recent Developments
9.2 Quicksilver Scientific
9.2.1 Quicksilver Scientific β-Nicotinamide Mononucleotide Basic Information
9.2.2 Quicksilver Scientific β-Nicotinamide Mononucleotide Product Overview
9.2.3 Quicksilver Scientific β-Nicotinamide Mononucleotide Product Market Performance
9.2.4 Quicksilver Scientific Business Overview
9.2.5 Quicksilver Scientific β-Nicotinamide Mononucleotide SWOT Analysis
9.2.6 Quicksilver Scientific Recent Developments
9.3 Age Science
9.3.1 Age Science β-Nicotinamide Mononucleotide Basic Information
9.3.2 Age Science β-Nicotinamide Mononucleotide Product Overview
9.3.3 Age Science β-Nicotinamide Mononucleotide Product Market Performance
9.3.4 Age Science β-Nicotinamide Mononucleotide SWOT Analysis
9.3.5 Age Science Business Overview
9.3.6 Age Science Recent Developments
9.4 Herbalmax
9.4.1 Herbalmax β-Nicotinamide Mononucleotide Basic Information
9.4.2 Herbalmax β-Nicotinamide Mononucleotide Product Overview
9.4.3 Herbalmax β-Nicotinamide Mononucleotide Product Market Performance
9.4.4 Herbalmax Business Overview
9.4.5 Herbalmax Recent Developments
9.5 Genex Formulas
9.5.1 Genex Formulas β-Nicotinamide Mononucleotide Basic Information
9.5.2 Genex Formulas β-Nicotinamide Mononucleotide Product Overview
9.5.3 Genex Formulas β-Nicotinamide Mononucleotide Product Market Performance
9.5.4 Genex Formulas Business Overview
9.5.5 Genex Formulas Recent Developments
9.6 Nutravita
9.6.1 Nutravita β-Nicotinamide Mononucleotide Basic Information
9.6.2 Nutravita β-Nicotinamide Mononucleotide Product Overview
9.6.3 Nutravita β-Nicotinamide Mononucleotide Product Market Performance
9.6.4 Nutravita Business Overview
9.6.5 Nutravita Recent Developments
9.7 Shinkowa Pharmaceutical
9.7.1 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide Basic Information
9.7.2 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide Product Overview
9.7.3 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide Product Market Performance
9.7.4 Shinkowa Pharmaceutical Business Overview
9.7.5 Shinkowa Pharmaceutical Recent Developments
9.8 Oriental Yeast
9.8.1 Oriental Yeast β-Nicotinamide Mononucleotide Basic Information
9.8.2 Oriental Yeast β-Nicotinamide Mononucleotide Product Overview
9.8.3 Oriental Yeast β-Nicotinamide Mononucleotide Product Market Performance
9.8.4 Oriental Yeast Business Overview
9.8.5 Oriental Yeast Recent Developments
9.9 Maac10 Formulas
9.9.1 Maac10 Formulas β-Nicotinamide Mononucleotide Basic Information
9.9.2 Maac10 Formulas β-Nicotinamide Mononucleotide Product Overview
9.9.3 Maac10 Formulas β-Nicotinamide Mononucleotide Product Market Performance
9.9.4 Maac10 Formulas Business Overview
9.9.5 Maac10 Formulas Recent Developments
9.10 EffePharm
9.10.1 EffePharm β-Nicotinamide Mononucleotide Basic Information
9.10.2 EffePharm β-Nicotinamide Mononucleotide Product Overview
9.10.3 EffePharm β-Nicotinamide Mononucleotide Product Market Performance
9.10.4 EffePharm Business Overview
9.10.5 EffePharm Recent Developments
9.11 Nutriop
9.11.1 Nutriop β-Nicotinamide Mononucleotide Basic Information
9.11.2 Nutriop β-Nicotinamide Mononucleotide Product Overview
9.11.3 Nutriop β-Nicotinamide Mononucleotide Product Market Performance
9.11.4 Nutriop Business Overview
9.11.5 Nutriop Recent Developments
9.12 Bontac
9.12.1 Bontac β-Nicotinamide Mononucleotide Basic Information
9.12.2 Bontac β-Nicotinamide Mononucleotide Product Overview
9.12.3 Bontac β-Nicotinamide Mononucleotide Product Market Performance
9.12.4 Bontac Business Overview
9.12.5 Bontac Recent Developments
9.13 CELFULL
9.13.1 CELFULL β-Nicotinamide Mononucleotide Basic Information
9.13.2 CELFULL β-Nicotinamide Mononucleotide Product Overview
9.13.3 CELFULL β-Nicotinamide Mononucleotide Product Market Performance
9.13.4 CELFULL Business Overview
9.13.5 CELFULL Recent Developments
9.14 ChromaDex
9.14.1 ChromaDex β-Nicotinamide Mononucleotide Basic Information
9.14.2 ChromaDex β-Nicotinamide Mononucleotide Product Overview
9.14.3 ChromaDex β-Nicotinamide Mononucleotide Product Market Performance
9.14.4 ChromaDex Business Overview
9.14.5 ChromaDex Recent Developments
9.15 Kingdomway
9.15.1 Kingdomway β-Nicotinamide Mononucleotide Basic Information
9.15.2 Kingdomway β-Nicotinamide Mononucleotide Product Overview
9.15.3 Kingdomway β-Nicotinamide Mononucleotide Product Market Performance
9.15.4 Kingdomway Business Overview
9.15.5 Kingdomway Recent Developments
10 β-Nicotinamide Mononucleotide Market Forecast by Region
10.1 Global β-Nicotinamide Mononucleotide Market Size Forecast
10.2 Global β-Nicotinamide Mononucleotide Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe β-Nicotinamide Mononucleotide Market Size Forecast by Country
10.2.3 Asia Pacific β-Nicotinamide Mononucleotide Market Size Forecast by Region
10.2.4 South America β-Nicotinamide Mononucleotide Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of β-Nicotinamide Mononucleotide by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global β-Nicotinamide Mononucleotide Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of β-Nicotinamide Mononucleotide by Type (2025-2030)
11.1.2 Global β-Nicotinamide Mononucleotide Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of β-Nicotinamide Mononucleotide by Type (2025-2030)
11.2 Global β-Nicotinamide Mononucleotide Market Forecast by Application (2025-2030)
11.2.1 Global β-Nicotinamide Mononucleotide Sales (Kilotons) Forecast by Application
11.2.2 Global β-Nicotinamide Mononucleotide Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings